These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35606332)

  • 21. Corrigendum to 'High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality' [Eur J Heart Fail 2021;23:919-932].
    Eur J Heart Fail; 2022 Mar; 24(3):591. PubMed ID: 34820986
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to 'Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT' [Eur J Heart Fail 2019;21:634-642].
    Eur J Heart Fail; 2019 Sep; 21(9):1166. PubMed ID: 31502341
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to 'Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2020;22:1315-1341].
    Eur J Heart Fail; 2021 Feb; 23(2):345. PubMed ID: 33783084
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to 'Departments involved during the first episode of acute heart failure and analysis of emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort' [Eur J Heart Fail 2019;21:1231-1244].
    Eur J Heart Fail; 2020 Nov; 22(11):2172. PubMed ID: 33459460
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to 'Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials' [Eur J Heart Fail 2020;11:2160-2171].
    Eur J Heart Fail; 2022 Mar; 24(3):591. PubMed ID: 34931409
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to 'The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association' [Eur J Heart Fail 2019;21:402-424].
    Ikonomidis I; Vlastos D
    Eur J Heart Fail; 2022 Aug; 24(8):1452. PubMed ID: 35138692
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to 'Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)' [Eur J Heart Fail 2020;22:1504-1524].
    Eur J Heart Fail; 2021 Feb; 23(2):345. PubMed ID: 33783083
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to 'The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study' [Eur J Heart Fail 2022;24:205-214].
    Eur J Heart Fail; 2022 Aug; 24(8):1453. PubMed ID: 35665579
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to 'Clinical picture and risk prediction of short-term mortality in cardiogenic shock' [Eur J Heart Fail] 2015 May;17(5):501-9. doi: 10.1002/ejhf.260.
    Eur J Heart Fail; 2015 Sep; 17(9):984. PubMed ID: 26377116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum to 'Transcatheter tricuspid valve therapies: exploring the dark side of the moon' [Eur J Heart Fail 2018;20:1063-1065].
    Eur J Heart Fail; 2020 Sep; 22(9):1743. PubMed ID: 33119217
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to 'Guidance on the management of left ventricular assist device (LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summary [Eur J Heart Fail 2021;23:1597-1609].
    Eur J Heart Fail; 2022 Apr; 24(4):733. PubMed ID: 35274419
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to: Athletes with valvular heart disease and competitive sports a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology. [Eur J Prev Cardiol 2021; doi:10.1093/eurjpc/zwab058].
    Eur J Prev Cardiol; 2021 Dec; 28(15):1733. PubMed ID: 34164648
    [No Abstract]   [Full Text] [Related]  

  • 33. Erratum to 'New-onset heart failure in the STOP-HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure' [Eur J Heart Fail 2020;22:378-380].
    Eur J Heart Fail; 2020 Jun; 22(6):1056. PubMed ID: 32731309
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Biogenic synthesis of silver nanoparticles: Antibacterial and cytotoxic potential' [Saudi J. Biol. Sci. 27(5) (2020) 1340-1351].
    Algebaly AS; Mohammed AE; Abutaha N; Elobeid MM
    Saudi J Biol Sci; 2022 Feb; 29(2):1269. PubMed ID: 35197793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addendum to the article: 'Improving risk prediction in heart failure using machine learning' [Eur J Heart Fail 2020;22:139-147].
    Eur J Heart Fail; 2020 Dec; 22(12):2399. PubMed ID: 33556232
    [No Abstract]   [Full Text] [Related]  

  • 36. Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial. Eur J Heart Fail 2017;19:1179-1185. doi: 10.1002/ejhf.750.
    Papadaki A; Martínez-González MÁ; Alonso-Gómez A; Rekondo J; Salas-Salvadó J; Corella D; Ros E; Fitó M; Estruch R; Lapetra J; García-Rodriguez A; Fiol M; Serra-Majem L; Pintó X; Ruiz-Canela M; Bulló M; Serra-Mir M; Sorlí JV; Arós F
    Eur J Heart Fail; 2019 Mar; 21(3):389-391. PubMed ID: 30883998
    [No Abstract]   [Full Text] [Related]  

  • 37. Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
    Anker SD; Schroeder S; Atar D; Bax JJ; Ceconi C; Cowie MR; Crisp A; Dominjon F; Ford I; Ghofrani HA; Gropper S; Hindricks G; Hlatky MA; Holcomb R; Honarpour N; Jukema JW; Kim AM; Kunz M; Lefkowitz M; Floch CL; Landmesser U; McDonagh TA; McMurray JJ; Merkely B; Packer M; Prasad K; Revkin J; Rosano GM; Somaratne R; Stough WG; Voors AA; Ruschitzka F
    Eur J Heart Fail; 2016 Jun; 18(6):727. PubMed ID: 27324688
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to: "Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice": [Eur.J.Pharmacol.670(2011)441-447].
    Tsai SJ; Chao CY; Yin MC
    Eur J Pharmacol; 2018 Jan; 819():293. PubMed ID: 29325911
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of hyponatremia in heart failure.
    Bettari L; Fiuzat M; Felker GM; O'Connor CM
    Heart Fail Rev; 2012 Jan; 17(1):17-26. PubMed ID: 20838881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corrigendum to: Antipsychotics and severe hyponatremia: A Swedish population-based case-control study. Eur J Intern Med. 2019 Feb;60:71-77.
    Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
    Eur J Intern Med; 2021 Oct; 92():142-143. PubMed ID: 34175184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.